Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E de Corso

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Rhinology|July 9, 2025
One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life studyE De Corso, M Corbò, G De Maio, et al.
Rhinology|March 31, 2023
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023W J Fokkens, A-S Viskens, V Backer, et al.
Rhinology|February 21, 2025
Remission in chronic rhinosinusitis with nasal polyps (CRSwNP)P W Hellings, E De Corso, V Backer, et al.
Frontiers in Allergy|March 11, 2025
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024P W Hellings, D M Conti, X Bertels, et al.
Frontiers in Allergy|May 30, 2024
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthmaG K Scadding, C Gray, D M Conti, et al.
Frontiers in Allergy|February 14, 2024
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthmaG K Scadding, M McDonald, V Backer, et al.
Allergy|April 25, 2026
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal PolypsL Klimek, J Mullol, S Reitsma, et al.
Rhinology|January 13, 2024
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNPW J Fokkens, E De Corso, V Backer, et al.
Frontiers in Allergy|August 14, 2023
EUFOREA summit in Brussels 2023: <i>inspiring the future of allergy & respiratory care</i>P W Hellings, S Lau, G K Scadding, et al.
Rhinology|March 5, 2025
Pocket guide: biologics in upper and lower airways in adultsW J Fokkens, V Backer, V J Lund, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Rhinology|July 9, 2025
One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life studyE De Corso, M Corbò, G De Maio, et al.
Rhinology|March 31, 2023
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023W J Fokkens, A-S Viskens, V Backer, et al.
Rhinology|February 21, 2025
Remission in chronic rhinosinusitis with nasal polyps (CRSwNP)P W Hellings, E De Corso, V Backer, et al.
Frontiers in Allergy|March 11, 2025
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024P W Hellings, D M Conti, X Bertels, et al.
Frontiers in Allergy|May 30, 2024
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthmaG K Scadding, C Gray, D M Conti, et al.
Frontiers in Allergy|February 14, 2024
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthmaG K Scadding, M McDonald, V Backer, et al.
Allergy|April 25, 2026
The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Utricaria, and Chronic Rhinosinusitis With Nasal PolypsL Klimek, J Mullol, S Reitsma, et al.
Rhinology|January 13, 2024
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNPW J Fokkens, E De Corso, V Backer, et al.
Frontiers in Allergy|August 14, 2023
EUFOREA summit in Brussels 2023: <i>inspiring the future of allergy & respiratory care</i>P W Hellings, S Lau, G K Scadding, et al.
Rhinology|March 5, 2025
Pocket guide: biologics in upper and lower airways in adultsW J Fokkens, V Backer, V J Lund, et al.
Pageof 7